Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xtant Medical Holdings Inc (XTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 9,226
  • Shares Outstanding, K 18,090
  • Annual Sales, $ 90,000 K
  • Annual Income, $ -19,490 K
  • 36-Month Beta 0.99
  • Price/Sales 0.11
  • Price/Cash Flow 0.00
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.55
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/03/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.48 +4.17%
on 04/06/17
0.70 -28.57%
on 03/29/17
-0.12 (-19.35%)
since 03/28/17
3-Month
0.29 +72.41%
on 01/31/17
1.18 -57.63%
on 03/08/17
+0.12 (+31.58%)
since 01/27/17
52-Week
0.29 +72.41%
on 01/31/17
2.64 -81.06%
on 05/12/16
-1.89 (-79.08%)
since 04/28/16

Most Recent Stories

More News
Xtant Medical Recognized as Montana Ambassador Business of the Year

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it has been named as...

XTNT : 0.50 (-1.96%)
Xtant(TM) Medical Receives Going Concern Opinion

Xtant(TM) Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that as previously disclosed in its Annual Report on...

XTNT : 0.50 (-1.96%)
Research Reports Initiation on Medical Equipment Stocks -- Varex Imaging, Masimo, Varian Medical, and Xtant Medical

Companies in the Medical Appliances and Equipment space are engaged in the manufacture of medical instruments such as dental and surgical appliances. They also tend to offer below-average dividend yields...

VAR : 90.74 (+1.93%)
VREX : 33.56 (-0.42%)
MASI : 102.74 (+0.86%)
XTNT : 0.50 (-1.96%)
Biotech and Pharma Stocks Rise on Optimism in the Markets Fueling Acquisitions and new Product Launches

PALM BEACH, Florida, March 7, 2017 /PRNewswire/ --

TGTX : 11.05 (-7.53%)
IPXL : 14.05 (+1.81%)
XTNT : 0.50 (-1.96%)
BLPH : 1.45 (-4.61%)
Xtant Medical to announce Fourth Quarter and Full Year 2016 Results on March 9th, 2017

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the fourth...

XTNT : 0.50 (-1.96%)
Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Carl O'Connell as the permanent CEO,...

ITOCY : 28.3600 (+0.60%)
XTNT : 0.50 (-1.96%)
XTNT Announces Closing of Registered Direct Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced the closing of...

XTNT : 0.50 (-1.96%)
XTNT Announces Registered Direct Offering

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has entered...

XTNT : 0.50 (-1.96%)
Xtant Medical Receives FDA Clearance for the Xsert(TM) Lumbar Expandable Interbody System

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that the U.S. Food and Drug Administration (FDA) has cleared...

XTNT : 0.50 (-1.96%)
Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, announced today the closing of its...

XTNT : 0.50 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Support & Resistance

2nd Resistance Point 0.54
1st Resistance Point 0.52
Last Price 0.50
1st Support Level 0.49
2nd Support Level 0.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.